Aktie A195990 ABPRO BIO CO., LTD.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Abpro Bio Co., Ltd.

Aktien

A195990

KR7195990007

A195990

Schlusskurs Korea S.E.
Andere Börsenplätze
 00:00:00 24.04.2024 		% 5 Tage % 1. Jan.
513 KRW -3.93% Intraday Chart für Abpro Bio Co., Ltd. +5.99% -5.87%
2023 Abpro Bio Co. Ltd. meldet Ergebnis für das erste Quartal bis zum 31. März 2023 CI
2022 Abpro Bio Co., Ltd. (KOSDAQ:A195990) hat die Übernahme von 30,911846% der Anteile an Zinitix Co., Ltd. (KOSDAQ:A303030) von Seoul Electronic Communication Co., Ltd., Wonwoo Kim, Soo-ah Kim. CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Abpro Bio Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
Abpro Bio Co., Ltd. cancelled the acquisition of 30.911846% stake in Zinitix Co., Ltd. from Seoul Electronic Communication Co., Ltd., Wonwoo Kim, Soo-ah Kim.
Abpro Bio Co., Ltd. agreed to acquire 30.911846% stake in Zinitix Co., Ltd. from Seoul Electronic Communication Co., Ltd., Wonwoo Kim, Soo-ah Kim for KRW 37 billion.
Abpro Bio Co., Ltd. announced that it has received KRW 5.999999552 billion in funding
Abpro Bio Co., Ltd. announced that it expects to receive KRW 4.99999895 billion in funding
Abpro Bio Co., Ltd. announced that it has received KRW 15 billion in funding from Meritz Securities Co., Ltd., Investment Arm
Abpro Bio Co., Ltd. announced that it expects to receive KRW 15 billion in funding from Meritz Securities Co., Ltd., Investment Arm
KUKBO Logistics Co.,Ltd acquired 19.35% stake in Bog International Co., Ltd. from Abpro Bio Co., Ltd. for KRW 2.8 billion.
Hwail Pharmaceutical Co.,Ltd. announced that it has received KRW 16.4999812 billion in funding from Osung Advanced Materials Co., Ltd., Abpro Bio Co., Ltd.
Abpro Bio Co., Ltd. announced that it has received KRW 10 billion in funding from Korea Bond Investment Advisory Co., Ltd.
Hwail Pharmaceutical Co.,Ltd. announced that it expects to receive KRW 16.4999812 billion in funding from Osung Advanced Materials Co., Ltd. and other investors
An unknown buyer cancelled the acquisition of 75% stake in UG Asset Co., Ltd. from Abpro Bio Co., Ltd..
Microtech Co.,Ltd cancelled the acquisition of 80% stake in Vitro Corporation from Abpro Bio Co., Ltd. from Abpro Bio Co., Ltd..
Abpro Bio Co., Ltd. announced that it expects to receive KRW 10 billion in funding from Korea Bond Investment Advisory Co., Ltd.
Abpro Bio Co., Ltd.(KOSDAQ:A195990) added to S&P Global BMI Index
An unknown buyer agreed to acquire 75% stake in UG Asset Co., Ltd. from Abpro Bio Co., Ltd. for KRW 3.2 billion.
Microtech Co.,Ltd agreed to acquire 80% stake in Vitro Corporation from Abpro Bio Co., Ltd. for KRW 6.8 billion.
Abpro Bio International, Inc. announced that it has received KRW 18.6608 billion in funding from Abpro Bio Co., Ltd.
Abpro Bio Co., Ltd. announced that it has received KRW 19.999999134 billion in funding
Abpro Bio Co., Ltd. announced that it has received KRW 14 billion in funding
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A195990 Aktie
  4. Nachrichten Abpro Bio Co., Ltd.
  5. Andere Sprachen